The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
Recruiting now · Not applicable
Conditions studied: Cardiac Conditions, Connective Tissue Diseases, Retinal Disease, Epilepsy in Children, Neurodevelopmental Disorders, Cancer, Polyposis
In brief
Genetic testing (GT) (including targeted panels, exome and genome sequencing) is increasingly being used for patient care as it improves diagnosis and health outcomes. In spite of these benefits, genetic testing is a complex and costly health service. This results in unequal access, increased wait times and inconsistencies in care. The use of e-health tools to support genetic testing delivery can result in a better patient experience and reduced distress associated with waiting for results and empower patients to receive and act on medical results. We have previously developed and tested an interactive, adaptable and patient-centred digital decision support tool (Genetics ADvISER) to be used for genetic testing decision making, and have now developed the Genetics Navigator (GN), a patient-centred e-health navigation platform for end-to-end genetic service delivery. The objective of this study is to evaluate the effectiveness of the GN in an RCT in reducing distress with patients and parents of patients being offered genetic testing. Results of this trial will be used to establish whether the GN is effective to use in practice. If effective, GN could fill a critical clinical care gap and improve health outcomes and service use by reducing counselling burden as well as overuse, underuse and misuse of services. These are concerns policy makers seek to address through the triple aims of health care1. This study represents a significant advance in personalized health by assessing the effectiveness of this novel, comprehensive e-health platform to ultimately improve genetic service delivery, accessibility, patient experiences, and patient outcomes.
Key facts
- Study ID
- NCT06455384
- Run by
- Unity Health Toronto
- People needed
- 170
- Starts
- 2025-10-28
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mount Sinai Hospital — Toronto, Ontario, Canada (enrolling)
- The Hospital for Sick Children — Toronto, Ontario, Canada (enrolling)
- Sunnybrook Hospital — Toronto, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.